Fidelity Investments
INBX icon

Fidelity Investments’s Inhibrx INBX Stock Holding History

Fidelity Investments’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.55M Buy
52,808
+6,539
+14% +$485K ﹤0.01% 2428
2025
Q4 		$3.66M Buy
46,269
+6,942
+18% +$473K ﹤0.01% 2388
2025
Q3 		$1.32M Buy
39,327
+256
+0.7% +$6.3K ﹤0.01% 2692
2025
Q2 		$558K Buy
39,071
+1,724
+5% +$22.3K ﹤0.01% 2916
2025
Q1 		$522K Sell
37,347
-1,409
-4% -$19.1K ﹤0.01% 2883
2024
Q4 		$597K Buy
38,756
+3,242
+9% +$49.4K ﹤0.01% 2853
2024
Q3 		$556K Buy
35,514
+7,285
+26% +$102K ﹤0.01% 2810
2024
Q2 		$400K Buy
+28,229
New +$441K ﹤0.01% 2809

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments's INBX Position: Q1 2026 in Review

Fidelity Investments increased its Inhibrx (INBX) stake by 14% in Q1 2026, buying an estimated $485K and bringing the position to 52,808 shares worth $3.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2428.

Fidelity Investments first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.66M in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Fidelity Investments held 52,808 shares of Inhibrx worth $3.55M as of Q1 2026.
  • Fidelity Investments bought 6,539 Inhibrx shares in Q1 2026, an estimated $485K.
  • Inhibrx made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2428 holding.
  • Fidelity Investments first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
  • Fidelity Investments's Inhibrx position peaked at $3.66M in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.